19Indexed trials
drug · Product Intelligence
Donepezil
Pipeline Intelligence
Donepezil: 19 indexed trials, 18 sponsors; 0 linked Orange Book patents and 13 FDA-linked events where matched.
18Sponsors
0Orange Book patent links
13FDA-linked events
Development evidence
NCT00142324Institute of Psychiatry, London · alzheimersPHASE4
NCT00177671University of Pittsburgh · alzheimersPHASE4
NCT00348309GlaxoSmithKline · alzheimersNA
NCT00505167Hospital Miguel Servet · alzheimersPHASE4
NCT01023867Samsung Medical Center · alzheimersNA
NCT01451749North China Pharmaceutical Group Corporation · dementia_otherPHASE3
NCT01466088Targacept Inc. · alzheimersPHASE2
NCT01658228New York State Psychiatric Institute · depressionPHASE4
NCT02051335AstraZeneca · alzheimersPHASE1
NCT02206620Oregon Health and Science University · parkinsonsPHASE2
NCT02305836Guang'anmen Hospital of China Academy of Chinese Medical Sciences · alzheimersPHASE2
NCT02580305Suven Life Sciences Limited · alzheimersPHASE2
NCT02857244University of Chicago · parkinsonsPHASE2
NCT03055741Daehwa Pharmaceutical Co., Ltd. · alzheimersPHASE2
NCT03599726Oregon Health and Science University · parkinsonsEARLY_PHASE1
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALMEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE · 2023-12-15
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2018-07-27
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2016-02-19
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2013-07-24
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2013-07-05
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2013-02-25
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2011-08-29
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2011-05-31
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2011-05-31
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2011-05-31
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2011-05-31
FDA_APPROVALDONEPEZIL HYDROCHLORIDE · 2011-05-31
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.